Company profile

RELMADA THERAPEUTICS, INC. insider acquisitions

Company CIK 0001553643 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
RLMD · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

13 dated transactions · 7 of 7 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsTRAVERSA SERGIOStock award
Dec 15, 2025RELMADA THERAPEUTICS, INC.Common StockTRAVERSA SERGIOPurchase
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsShenouda MagedStock award
Dec 15, 2025RELMADA THERAPEUTICS, INC.Common StockShenouda MagedPurchase
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsEnce ChuckStock award
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsFedeli FabianaStock award
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsGLASSPOOL JOHNStock award
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsKelly Paul EdwardStock award
Dec 12, 2025RELMADA THERAPEUTICS, INC.Stock Appreciation RightsCASAMENTO CHARLES JStock award
Nov 5, 2025RELMADA THERAPEUTICS, INC.Common StockEnce ChuckPurchase
Nov 5, 2025RELMADA THERAPEUTICS, INC.Common StockTRAVERSA SERGIOPurchase
Nov 5, 2025RELMADA THERAPEUTICS, INC.Common StockShenouda MagedPurchase
Nov 5, 2025RELMADA THERAPEUTICS, INC.Common StockKelly Paul EdwardPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

RLMD · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
TRAVERSA SERGIOChief Executive Officer · Director
Stock awardStock Appreciation RightsDerivative security · Code A1,198,0000Value: 0Currency not specifiedView ↗
Trade:
TRAVERSA SERGIOChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P27,5004.12 *Value: 113,300Currency not specifiedView ↗
Trade:
Shenouda MagedChief Financial Officer
Stock awardStock Appreciation RightsDerivative security · Code A828,0000Value: 0Currency not specifiedView ↗
Trade:
Shenouda MagedChief Financial Officer
PurchaseCommon StockNon-derivative security · Code P11,6654.12Value: 48,059.8Currency not specifiedView ↗
Trade:
Ence ChuckCA and CO
Stock awardStock Appreciation RightsDerivative security · Code A828,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Appreciation RightsDerivative security · Code A164,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Appreciation RightsDerivative security · Code A164,0000Value: 0Currency not specifiedView ↗
Trade:
Kelly Paul EdwardCOO · Director
Stock awardStock Appreciation RightsDerivative security · Code A828,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Appreciation RightsDerivative security · Code A164,0000Value: 0Currency not specifiedView ↗
Trade:
Ence ChuckCAO and COO
PurchaseCommon StockNon-derivative security · Code P136,0002.2Value: 299,200Currency not specifiedView ↗
Trade:
TRAVERSA SERGIOChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P272,5002.2Value: 599,500Currency not specifiedView ↗
Trade:
Shenouda MagedChief Financial Officer
PurchaseCommon StockNon-derivative security · Code P500,0002.2Value: 1,100,000Currency not specifiedView ↗
Trade:
Kelly Paul EdwardChief Operating Officer · Director
PurchaseCommon StockNon-derivative security · Code P90,0002.2Value: 198,000Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →